in vitro Biology
in vitro Biology Services
Pharmaron’s in vitro biology team supports drug discovery programs to identify and optimize new test articles. We assist in projects of any scope, be it a single screening study or comprehensive assay development and screening support within integrated drug discovery projects.
Our extensive range of in vitro assay services caters to a wide spectrum of projects, from standard in vitro assays to custom-tailored disease-specific assay cascades for therapeutic areas such as oncology, neurology, immunology, metabolic, or cardiovascular diseases.
Through direct conversations with our lead scientists, we facilitate efficient project execution based on our clients’ needs. Our assay development team has expertise in various assays for characterizing compounds, from basic binding assays to elaborate mechanism-of-action assays via biophysical methods.
Our purpose-built in vitro biology facilities have state-of-the-art instrumentation for high automation. This infrastructure, combined with our smart compound management system, positions us to provide the industry with the fastest turnaround times for in vitro assay services.
Pharmaron’s in vitro Biology Services Support Every Phase of Drug Discovery
Drug Modalities Supported by Pharmaron
- Small molecules
- Protein degraders and stabilizers
- Peptides
- Oligonucleotides
- ADCs and other conjugates
- Biologics
- Cell and gene therapies
Why work with Pharmaron?
- Rapid turnaround times
- Routine biochemical assays: 3 days
- Routine cellular assays: 5 days
- Cell line generation: 4 weeks
- 630 drug discovery projects completed per year
- One-campus concept and integrated compound management for chemistry, in vitro biology, and DMPK for accelerated design-make-test cycles
- Thorough validation of every assay
- Reproducibility ensured via assay performance indicators across projects, plates, and dates
